Search alternatives:
point decrease » point increase (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
541
Table_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.docx
Published 2022“…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
-
542
Image_1_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg
Published 2022“…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
-
543
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
Published 2013“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
-
544
Amplitude for A/L = 0.29.
Published 2025“…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
-
545
Amplitude for A/L = 0.338.
Published 2025“…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
-
546
Amplitude for A/L = 0.02.
Published 2025“…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
-
547
Amplitude for A/L = 0.03.
Published 2025“…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
-
548
-
549
Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells.
Published 2016“…<p>(<b>A</b>) Significant decreases in the proportions of PV+ cells were observed in fSSp, SSp, vAud and in Vis, but not MPFC. …”
-
550
-
551
-
552
-
553
-
554
-
555
-
556
-
557
AMPs are increased in lesional HS, but DCD and other sweat-gland associated proteins are decreased.
Published 2019“…<p>(A) Volcano plot showing increased or decreased genes in HS. …”
-
558
A Point Mutation in a lincRNA Upstream of <i>GDNF</i> Is Associated to a Canine Insensitivity to Pain: A Spontaneous Model for Human Sensory Neuropathies
Published 2016“…This variant, located 90 kb upstream of the <i>GDNF</i> gene, a highly relevant neurotrophic factor candidate gene, lies in a long intergenic non-coding RNAs (lincRNA), <i>GDNF-AS</i>. …”
-
559
Structural details for each point mutation studied by X-ray crystallography in this study.
Published 2023Subjects: -
560
Participant characteristics (non-weighted).
Published 2024“…Differences were noted between the models of only males and only females. Decreased walking endurance is associated with a decreased likelihood of walking in the community—a factor that can be addressed by rehabilitation professionals and in community based programs.…”